SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-24-011136
Filing Date
2024-03-04
Accepted
2024-03-04 17:35:47
Documents
1
Group Members
INNOVIVA STRATEGIC OPPORTUNITIES LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A ef20023182_sc13da.htm SC 13D/A 84126
  Complete submission text file 0001140361-24-011136.txt   86250
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Subject) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-44887 | Film No.: 24716468
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filed by) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)